IndiTreat® Therapy Design

The backbone in the IndiTreat® therapy Design offering is the IndiTreat® test that delivers a comprehensive drug sensitivity analysis. 2cureX has collected comprehensive knowledge on treatment regimens within different patient populations. This information will be available to the oncologist to design the IndiTreat® screening panel. The IndiTreat® drug sensitivity data are compared to genomic/mutational analysis. Further 2cureX is analysing the morphological characteristics of the micro-tumors by using artificial intelligence algorithms.

Micro-tumors not used for the IndiTreat® test will be stored in the IndiTreat® biobank.

All data are stored in 2cureX’s database, IndiBase™.

Subscription for 2cureX News and Press Releases

Language News type
Your information

Data storage policy

Contact information

2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark| Phone: +45 2211 5399| E-mail:

Privacy Policy | Imprint